Ifenek (Ifenec)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceEconazoleEconazole
Similar drugsTo uncover
  • Gino-Pevaril®
    suppositories the vagina. 
    Johnson & Johnson, LLC     Russia
  • Ifenek
    solution externally 
    Italfarmaco SpA     Italy
  • Ifenek
    powder externally 
    Italfarmaco SpA     Italy
  • Ifenek
    suppositories the vagina. 
    Italfarmaco SpA     Italy
  • Ifenek
    cream externally 
    Italfarmaco SpA     Italy
  • Ecodax®
    cream externally 
    Unik Pharmaceutical Laboratories     India
    • Dosage form: & nbspVaginal suppositories
    Composition:

    1 suppository vaginal contains:

    Active substance: econazole nitrate - 150.0 mg.

    Excipients: semisynthetic glycerides (Novata IV B, Miritol 318).

    Description:

    Suppressor torpedo shape from white to yellow-white.

    Pharmacotherapeutic group:Antifungal agent
    ATX: & nbsp

    G.01.A.F.05   Econazole

    Pharmacodynamics:

    Econazole is a synthetic derivative of imidazole. Has a local antifungal and antibacterial effect. It inhibits the biosynthesis of ergosterol, which regulates the permeability of the cell wall of microorganisms. It dissolves easily in lipids and penetrates well into tissues. Active against dermatophytes Trichophyton, Microsporum, Epidermophyton, yeast-like fungi of the genus Candida, mold fungi, and Malassezia furfur (Pityrosporum orbiculare), which causes multi-colored lichen and Corinebacterium minutissimum; some gram-positive bacteria (streptococci, staphylococci).

    Pharmacokinetics:

    Econazole nitrate is poorly absorbed after insertion into the vagina.

    Indications:

    Vulvaceous-vaginal mycoses.

    Contraindications:

    Hypersensitivity to one of the components of the drug.

    Pregnancy and lactation:

    The use of the drug during pregnancy is possible only in those cases when the potential benefit to the mother exceeds the possible risk to the fetus. If you need to use the drug during lactation, you should decide whether to stop breastfeeding.

    Dosing and Administration:

    Only for adults. The vaginal suppository is injected deep into the vagina, in the supine position, just before bedtime for 3 days.

    In case of insufficient effectiveness of a standard 3-day treatment of vaginal candidiasis it may increase to six days and conducting a repeated course of 10 days.

    Side effects:

    In the case of Iphenec, in rare cases, irritation, redness vaginal mucosa and vulva, itching and burning in these areas. If after application the drug will have side effects that are not listed in this information, then they should be reported to the doctor.

    Overdose:

    Up to now, there is no information on overdose.

    Interaction:Clinical trials and use of the drug in medical practice have not revealed incompatibility or interaction with other drugs. It is recommended to inform the doctor about simultaneous treatment with other medications.
    Special instructions:

    During menstruation the drug is administered intravaginally according to the usual scheme.

    With vulvar-vaginal mycoses, treatment and sexual partner are mandatory.

    Effect on the ability to drive transp. cf. and fur:

    Does not affect the ability to drive vehicles and mechanisms.

    Form release / dosage:

    Vaginal suppositories of 150 mg.

    Packaging:

    For 6 suppositories in a PVC strip.

    One strip together with instructions for use in a cardboard box.

    Storage conditions:

    Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.

    Shelf life:

    2 years. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N013922 / 02
    Date of registration:07.04.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:Italfarmaco SpAItalfarmaco SpA Italy
    Manufacturer: & nbsp
    Representation: & nbspITALFARMAKO SpA ITALFARMAKO SpA Italy
    Information update date: & nbsp15.11.2017
    Illustrated instructions
      Instructions
      Up